About AbbVie
AbbVie is a research-driven pharmaceutical company spun off from Abbott Laboratories in 2013, headquartered in North Chicago, Illinois. Its immunology franchise — Humira, Skyrizi, and Rinvoq — covers conditions including rheumatoid arthritis, Crohn's disease, ulcerative colitis, and atopic dermatitis. The company's aesthetics business, picked up via the $63 billion acquisition of Allergan in 2020, includes Botox, Juvederm, and the broader Allergan Aesthetics portfolio. AbbVie also has a deep oncology pipeline anchored by Imbruvica, Venclexta, and the antibody-drug conjugate Elahere from its 2024 acquisition of ImmunoGen.
About the AbbVie logo
The AbbVie (ABBV) logo is part of the Tickericons pack — a hand-crafted set of logos for every company in the S&P 500. Each logo is manually redrawn to a consistent grid, weight, and corner radius so ABBV sits cleanly next to other tickers in cap tables, dashboards, equity research, and fintech UI.
You get two styles: the trademark (just the symbol, ideal for grids and tight UI) and the full logo (mark plus wordmark, ideal when there's room to breathe). Both ship as scalable SVG, high-resolution PNG, and reusable Figma components.
AbbVie was added to the S&P 500 on Dec 31, 2012 and is currently classified under the Health Care sector.
Index history
Jan 2, 2013 · Added to the S&P 500
ABBV spun off from Abbott Labs (ABT)
Other Health Care companies
See all →abt
Abbott LaboratoriesMar 4, 195725,279a
Agilent TechnologiesJun 5, 20009,480algn
Align TechnologyJun 19, 20173,257amgn
AmgenJan 2, 199212,557bax
Baxter InternationalSep 30, 197219,590bdx
Becton Dickinson and CoSep 30, 197219,590tech
Bio-Techne CorporationAug 30, 20211,724biib
BiogenNov 13, 20038,224bsx
Boston Scientific CorporationFeb 24, 199511,408bmy
Bristol-Myers SquibbMar 4, 195725,279
Get all S&P 500 logos
One-time payment. SVG, PNG, and a Figma library. Free updates as the index changes.